RESUMEN
Emerging and re-emerging viruses, such as Zaire Ebola virus (EBOV), pose a global threat and require immediate countermeasures, including the rapid development of effective vaccines that are easy to manufacture. Synthetic self-amplifying RNAs (saRNAs) attend to these needs, being safe and strong immune stimulators that can be inexpensively produced in large quantities, using cell-free systems and good manufacturing practice. Here, the first goal was to develop and optimize an anti-EBOV saRNA-based vaccine in terms of its antigen composition and route of administration. Vaccinating mice with saRNAs expressing the EBOV glycoprotein (GP) alone or in combination with the nucleoprotein (NP) elicited antigen-specific immune responses. GP-specific antibodies showed neutralizing activity against EBOV. Strong CD4+ T cell response against NP and GP and CD8+ T cell response against NP were detected by ELISpot assays. Intramuscular vaccination with saRNAs conferred better immune response than intradermal. Finally, mice vaccinated in a prime-boost regimen with saRNAs encoding both GP and NP or with GP alone survived an EBOV infection. In addition, a single dose of GP and NP saRNAs was also protective against fatal EBOV infection. Overall, saRNAs expressing viral antigens represent a promising vaccine platform.
Asunto(s)
Vacunas contra el Virus del Ébola , Ebolavirus , Fiebre Hemorrágica Ebola , Animales , Ratones , Fiebre Hemorrágica Ebola/prevención & control , Anticuerpos Antivirales , Anticuerpos Neutralizantes , Ebolavirus/genética , Glicoproteínas/genética , Vacunas contra el Virus del Ébola/genéticaRESUMEN
OBJECTIVES: Sprays containing fine and ultrafine particles are commonly used for optical scanning. The aim of this study was to measure the particle exposure of patient and dentist during application of scanning spray and to evaluate measures for its reduction. MATERIALS AND METHODS: A lower molar in a dental simulator was powdered with scanning spray. Patient's particle exposure was measured by a condensation particle counter in the nasal region of the simulator without (P) and with rubber dam (PC). Dentist's exposure (D) was measured behind a surgical mask. Particle concentrations were determined 5-fold without suction (NS), using conventional dental suction (CDS), or high volume evacuation (HVE). RESULTS: Mean background air particle concentrations for the patient were 3.3 × 10(3) and 1.3 × 10(3) pt/cm(3) for the dentist. Particle concentrations increased after spraying; mean cumulated additional particle exposures for the patient were the following: P-NS 7.2 × 10(6), P-CDS 4.6 × 10(6), P-HVE 2.4 × 10(4); using rubber dam: PC-NS 3.6 × 10(6), PC-CDS 3.3 × 10(5), PC-HVE 2.2 × 10(5). The particle exposures of the dentist were the following: D-NS 9.7 × 10(5), D-CDS 1.8 × 10(5), D-HVE 1.6 × 10(4). CONCLUSIONS: The use of HVE is recommended to reduce exposure of patients and dental staff to fine and ultrafine particles when using scanning sprays. CLINICAL RELEVANCE: Effective protection is available for staff and patient by means of high volume evacuation. In patients suffering from obstructive lung diseases, the use of scanning sprays should be avoided altogether.
Asunto(s)
Polvo , Modelos Dentales , Exposición Profesional/análisis , Exposición Profesional/normas , Auxiliares Dentales , Odontólogos , Personal de Salud , Humanos , Diente Molar/cirugía , TitanioRESUMEN
The ability to control autoreactive T cells without inducing systemic immune suppression is the major goal for treatment of autoimmune diseases. The key challenge is the safe and efficient delivery of pharmaceutically well-defined antigens in a noninflammatory context. Here, we show that systemic delivery of nanoparticle-formulated 1 methylpseudouridine-modified messenger RNA (m1Ψ mRNA) coding for disease-related autoantigens results in antigen presentation on splenic CD11c+ antigen-presenting cells in the absence of costimulatory signals. In several mouse models of multiple sclerosis, the disease is suppressed by treatment with such m1Ψ mRNA. The treatment effect is associated with a reduction of effector T cells and the development of regulatory T cell (Treg cell) populations. Notably, these Treg cells execute strong bystander immunosuppression and thus improve disease induced by cognate and noncognate autoantigens.
Asunto(s)
Efecto Espectador/inmunología , Encefalomielitis Autoinmune Experimental/terapia , Terapia de Inmunosupresión/métodos , Esclerosis Múltiple/terapia , Vacunas Sintéticas/uso terapéutico , Animales , Células Presentadoras de Antígenos , Autoantígenos/genética , Inflamación/inmunología , Ratones , Ratones Endogámicos C57BL , Seudouridina/análogos & derivados , Seudouridina/química , ARN Mensajero/efectos adversos , ARN Mensajero/química , ARN Mensajero/genética , Linfocitos T Reguladores/inmunología , Vacunas Sintéticas/efectos adversos , Vacunas de ARNmRESUMEN
Alterations in dendritic spine numbers are linked to deficits in learning and memory. While we previously revealed that postsynaptic plasticity-related gene 1 (PRG-1) controls lysophosphatidic acid (LPA) signaling at glutamatergic synapses via presynaptic LPA receptors, we now show that PRG-1 also affects spine density and synaptic plasticity in a cell-autonomous fashion via protein phosphatase 2A (PP2A)/ß1-integrin activation. PRG-1 deficiency reduces spine numbers and ß1-integrin activation, alters long-term potentiation (LTP), and impairs spatial memory. The intracellular PRG-1 C terminus interacts in an LPA-dependent fashion with PP2A, thus modulating its phosphatase activity at the postsynaptic density. This results in recruitment of adhesome components src, paxillin, and talin to lipid rafts and ultimately in activation of ß1-integrins. Consistent with these findings, activation of PP2A with FTY720 rescues defects in spine density and LTP of PRG-1-deficient animals. These results disclose a mechanism by which bioactive lipid signaling via PRG-1 could affect synaptic plasticity and memory formation.
Asunto(s)
Espinas Dendríticas/metabolismo , Factores de Intercambio de Guanina Nucleótido/metabolismo , Integrina beta1/metabolismo , Lisofosfolípidos/metabolismo , Plasticidad Neuronal/fisiología , Proteína Fosfatasa 2/metabolismo , Sinapsis/fisiología , Animales , Células Cultivadas , Espinas Dendríticas/genética , Adhesiones Focales/fisiología , Factores de Intercambio de Guanina Nucleótido/genética , Hipocampo/citología , Hipocampo/metabolismo , Integrina beta1/genética , Potenciación a Largo Plazo , Microdominios de Membrana/metabolismo , Ratones , Ratones Noqueados , Proteína Fosfatasa 2/genética , Factores de Intercambio de Guanina Nucleótido Rho , Transducción de SeñalRESUMEN
Proteasomes are the main cytosolic proteases responsible for generating peptides for antigen processing and presentation in the MHC (major histocompatibility complex) class-I pathway. Purified 20S and 26S proteasomes have been widely used to study both specificity and efficiency of antigen processing. Here, we describe the purification of active human 20S and 26S proteasomes from human erythrocytes by DEAE-ion exchange chromatography, ammonium sulfate precipitation, glycerol density gradient centrifugation, and Superose-6 size exclusion chromatography and their characterization using fluorogenic substrates and specific inhibitors.
Asunto(s)
Fraccionamiento Químico/métodos , Citosol/enzimología , Pruebas de Enzimas/métodos , Complejo de la Endopetidasa Proteasomal/aislamiento & purificación , Complejo de la Endopetidasa Proteasomal/metabolismo , Acetilcisteína/análogos & derivados , Acetilcisteína/farmacología , Adsorción , Sulfato de Amonio/química , Western Blotting , Precipitación Química , Cromatografía en Gel , Cromatografía por Intercambio Iónico , Diálisis , Electroforesis en Gel de Poliacrilamida , Eritrocitos/citología , Glicerol/química , Humanos , Oligopéptidos/farmacología , Inhibidores de Proteasoma/farmacología , Proteolisis , UltracentrifugaciónRESUMEN
Oligodendrocytes synthesize the CNS myelin sheath by enwrapping axonal segments with elongations of their plasma membrane. Spatial and temporal control of membrane traffic is a prerequisite for proper myelin formation. The major myelin proteolipid protein (PLP) accumulates in late endosomal storage compartments and multivesicular bodies (MVBs). Fusion of MVBs with the plasma membrane results in the release of the intralumenal vesicles, termed exosomes, into the extracellular space. Here, we show that cultured oligodendrocytes secrete exosomes carrying major amounts of PLP and 2'3'-cyclic-nucleotide-phosphodiesterase (CNP). These exosomes migrated at the characteristic density of 1.10-1.14â g/mL in sucrose density gradients. Treatment of primary oligodendrocytes with the calcium-ionophore ionomycin markedly increased the release of PLP-containing exosomes, indicating that oligodendroglial exosome secretion is regulated by cytosolic calcium levels. A proteomic analysis of the exosomal fraction isolated by sucrose density centrifugation revealed in addition to PLP and CNP, myelin basic protein (MBP) and myelin oligodendrocyte glycoprotein (MOG) as constituents of oligodendroglial exosomes, together with a striking group of proteins with proposed functions in the relief of cell stress. Oligodendroglial exosome secretion may contribute to balanced production of myelin proteins and lipids, but in addition exosomes may embody a signaling moiety involved in glia-mediated trophic support to axons.